Compare InMode Ltd (INMD) vs MetLife Inc. Common Stock (MET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
InMode Ltd vs MetLife Inc. Common Stock — how do they compare? InMode Ltd trades at $14.07 (market cap $806.05M), while MetLife Inc. Common Stock trades at $98.97 (market cap $60.87B). The key difference: MetLife Inc. Common Stock is far larger — about 75.5× InMode Ltd's market cap, and MetLife Inc. Common Stock pays a 2.47% dividend while InMode Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 29 Days and MetLife Inc. Common Stock for 0 Days on average.
| INMD | MET | |
|---|---|---|
Market Cap | $806.05M | $60.87B |
Volume | 511,446 | 3,175,937 |
Sector | Health | Financials |
52-Week High | $16.62 | $99.95 |
52-Week Low | $12.76 | $67.70 |
Typical Hold Time | 29 Days | 0 Days |
Enterprise Value | $309.39M | $81.79B |
Dividend Yield | — | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INMD trades at $14.01, showing minimal daily movement with a 0.14% gain. The stock faces bearish technical signals despite attractive valuation metrics including a P/E of 11.58 and EV/EBITDA of 4.43. Recent earnings show mixed results with Q2 2026 beating expectations but Q1 2026 missing, while the company faces shareholder activism from Steel Partners' $16.75 per share acquisition offer. Revenue guidance for 2026 remains stable at $365M-$375M.
The investment case balances strong profitability margins against technical weakness and activist pressure. With 45% analyst buy ratings and no sell recommendations, fundamental value appears intact, but near-term price action suggests caution. Key catalysts include Q3 2026 earnings and resolution of the acquisition proposal, while risks include execution challenges and macroeconomic headwinds affecting aesthetic medicine demand.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About InMode Ltd
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →About MetLife Inc. Common Stock
MetLife provides insurance, annuities, employee benefits, and asset management services. Its products serve individuals, employers, and institutions.
Read more on MET →
